| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | China | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | United States | 3 | |
| #6 | WIPO (World Intellectual Property Organization) | 3 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology | |
| #4 | Measurement | |
| #5 | Biotechnology | |
| #6 | Macromolecular chemistry and polymers |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gilles Guichard | 9 |
| #2 | Guichard Gilles | 8 |
| #3 | Renia Laurent | 7 |
| #4 | Gersande Lena | 7 |
| #5 | Lallemand Eliette | 7 |
| #6 | Lena Gersande | 7 |
| #7 | Laurent Renia | 3 |
| #8 | Eliette Lallemand | 3 |
| #9 | Muller Pascal | 3 |
| #10 | Lambeau Gerard | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2019352341A1 | Modified peptides and their use for treating systemic lupus erythematosus | |
| AU2006331357A1 | Compositions and methods for synthesizing novel heterocyclic therapeutics | |
| CN101395143A | Aza heterocyclics for the treatment of malaria or aids | |
| EP1965806A2 | 1, 3, 5-triazepin-2, 6-diones for the treatment of malaria | |
| AU2006331355A1 | Compositions and methods for the inhibition of phospholipase A2 |